Replies to post #199201 on Biotech Values

[DewDiligence]

VTVT starts phase-2 trial of TTP273 in T2D:

http://finance.yahoo.com/news/vtv-therapeutics-initiates-phase-2-120000796.html

VTVT has two distinct programs in type2 diabetes; both are expected to report phase-2 data during 2016.